43 , 44 , 45 , 46 , 47 , 48 However, excessive BP lowering targeting a SBP <140 mm Hg is not recommended, as it offers no additional benefits and may potentially increase the risk of renal dysfunction; thus, it is categorized as “LOE IIa and GOR B.” In addition, recent studies have shown a clear trend toward using SBP as the primary target, and to enhance practicality in clinical settings, the guideline eliminates the criteria based on MAP, unifying the recommendations around SBP.
← all excerpts
Update of the Korean Clinical Practice Guidelines for Stroke: Blood Pressure Management.
1
—
—